This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Basck Invest Limited, Technische Universitát Dresden, Other. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Germana Rappa: Innovator in Protein Complex Inhibition
Introduction
Germana Rappa is a notable inventor based in Las Vegas, NV (US). She has made significant contributions to the field of molecular biology, particularly in the inhibition of protein complexes that play a crucial role in intercellular communication.
Latest Patents
Germana Rappa holds a patent titled "Inhibition of a tripartite VOR protein complex in multicellular organisms." This patent relates to methods of inhibiting a tripartite VAP-A, ORP3, and Rab7 (VOR) protein complex in multicellular organisms. The disclosure outlines methods for identifying agents that inhibit this complex and discusses the medical applications of these agents. Inhibition of the VOR complex interferes with mechanisms of intercellular communication, which can be mediated by receptor-ligand interactions and extracellular vesicles (EVs), as well as viral infections that involve the transport of endocytosed biomaterials to the nucleus of recipient cells. Germana Rappa has 1 patent to her name.
Career Highlights
Throughout her career, Germana Rappa has worked with esteemed institutions, including Technische Universität Dresden and Basck Invest Limited. Her work has focused on advancing our understanding of protein interactions and their implications in medical science.
Collaborations
Germana has collaborated with notable professionals in her field, including Aurelio Lorico and Denis Corbeil. These collaborations have contributed to her research and innovations in protein complex inhibition.
Conclusion
Germana Rappa is a pioneering inventor whose work in protein complex inhibition has the potential to impact medical science significantly. Her contributions continue to advance our understanding of intercellular communication and its implications for health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile